|
WO2010062640A1
|
|
Methods for treating idiopathic pulmonary fibrosis and associated complications
|
|
WO2009079391A1
|
|
Benzofuran anilide histone deacetylase inhibitors
|
|
CA2639336A1
|
|
Therapeutic combinations and methods for cardiovascular improvement and treating cardiovascular disease
|
|
CA2697057A1
|
|
Therapy for complications of diabetes
|
|
EP2170882A1
|
|
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
WO2008100803A1
|
|
Antihypertensive drug combination
|
|
CA2669535A1
|
|
Ambrisentan combined with a renin inhibitor for hypertensive disorders
|
|
CA2668724A1
|
|
Darusentan oral dosage form
|
|
CA2655144A1
|
|
Antihypertensive therapy method
|
|
EP1996233A2
|
|
Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
|
|
WO2007098387A2
|
|
Antihypertensive therapy
|
|
JP2009256209A
|
|
Antihypertensive therapy
|
|
WO2007073555A1
|
|
Use of 4, 7-dihydrothieno [2, 3-b] pyridine compounds in the treatment of cardiovascular diseases
|
